✦ LIBER ✦
In lupus nephritis, the benefit of rituximab monotherapy, as opposed to rituximab plus cyclophosphamide combination therapy, remains uncertain: Comment on the article by Sfikakis et al
✍ Scribed by Ronald van Vollenhoven; Iva Gunnarsson
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 41 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.